ProShare Advisors’s Inari Medical, Inc. Common Stock NARI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-15,898
| Closed | -$812K | – | 2278 |
|
2024
Q4 | $812K | Buy |
15,898
+4,911
| +45% | +$251K | ﹤0.01% | 1011 |
|
2024
Q3 | $453K | Buy |
10,987
+2,787
| +34% | +$115K | ﹤0.01% | 1191 |
|
2024
Q2 | $395K | Sell |
8,200
-4,119
| -33% | -$198K | ﹤0.01% | 1112 |
|
2024
Q1 | $591K | Buy |
12,319
+553
| +5% | +$26.5K | ﹤0.01% | 990 |
|
2023
Q4 | $764K | Buy |
11,766
+1,925
| +20% | +$125K | ﹤0.01% | 832 |
|
2023
Q3 | $644K | Sell |
9,841
-52
| -0.5% | -$3.4K | ﹤0.01% | 823 |
|
2023
Q2 | $575K | Buy |
9,893
+1,077
| +12% | +$62.6K | ﹤0.01% | 892 |
|
2023
Q1 | $544K | Sell |
8,816
-366
| -4% | -$22.6K | ﹤0.01% | 878 |
|
2022
Q4 | $584K | Buy |
9,182
+1,239
| +16% | +$78.8K | ﹤0.01% | 890 |
|
2022
Q3 | $577K | Buy |
7,943
+654
| +9% | +$47.5K | ﹤0.01% | 865 |
|
2022
Q2 | $496K | Buy |
7,289
+835
| +13% | +$56.8K | ﹤0.01% | 938 |
|
2022
Q1 | $584K | Sell |
6,454
-1,067
| -14% | -$96.5K | ﹤0.01% | 1182 |
|
2021
Q4 | $687K | Buy |
7,521
+3,163
| +73% | +$289K | ﹤0.01% | 1250 |
|
2021
Q3 | $353K | Sell |
4,358
-4,461
| -51% | -$361K | ﹤0.01% | 1423 |
|
2021
Q2 | $823K | Buy |
8,819
+4,397
| +99% | +$410K | ﹤0.01% | 1154 |
|
2021
Q1 | $473K | Buy |
+4,422
| New | +$473K | ﹤0.01% | 1479 |
|